Antimicrobial activity of N-acylphenothiazines and their influence on lipid model membranes and erythrocyte membranes

Arzneimittel-Forschung/Drug Research

Volumn 53, Issue 8, 2003, Pages 590-599

  Motohashi, Noboru ^a   Kawase, Masami ^b   Molnár, Joseph ^c   Ferenczy, Lajos ^d   Wesolowska, Olga ^e   Hendrich, Andrzej B ^e   Bobrowska Hägerstrand, Malgorzata ^f   Hägerstrand, Henry ^f   Michalak, Krystyna ^e  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

^c UNIVERSITY OF SZEGED   (Hungary)

^d UNIVERSITY OF SZEGED   (Hungary)

^e WROCLAW MEDICAL UNIVERSITY   (Poland)

^f ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

N Acylphenothiazines, anti microbioal activity, erythrocyte membrane, lipid model membrane, liposome

Indexed keywords

10 (3 AMINOPROPYL) 10H PHENOTHIAZINE MALEATE; 10 (3 AMINOPROPYL) 2 CHLORO 10H PHENOTHIAZINE MALEATE; 10 (3 AMINOPROPYL) 2 TRIFLUOROMETHYL 10H PHENOTHIAZINE MALEATE; 10 (3 N ACETYLAMINOPROPYL) 2 CHLORO 10H PHENOTHIAZINE; 10 (3 N METHANESULFONYLAMINOPROPYL) 2 CHLORO 10H PHENOTHIAZINE; 10 (3 N METHOXYCARBONYLAMINOPROPYL) 2 CHLORO 10H PHENOTHIAZINE; 10 (4 AMINOBUTYL) 10H PHENOTHIAZINE MALEATE; 10 (4 AMINOBUTYL) 2 CHLORO 10H PHENOTHIAZINE MALEATE; 10 (4 AMINOBUTYL) 2 TRIFLUOROMETHYL 10H PHENOTHIAZINE MALEATE; 10 (N ACETYL 3 AMINOPROPYL) 10H PHENOTHIAZINE; 10 (N ACETYL 3 AMINOPROPYL) 2 TRIFLUOROMETHYL 10H PHENOTHIAZINE; 10 (N ACETYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 10 (N ACETYL 4 AMINOBUTYL) 2 CHLORO 10H PHENOTHIAZINE; 10 (N ACETYL 4 AMINOBUTYL) 2 TRIFLUOROMETHYL 10H PHENOTHIAZINE; 10 (N METHANESULFONYL 3 AMINOPROPYL) 10H PHENOTHIAZINE; 10 (N METHANESULFONYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 10 (N METHOXYCARBONYL 3 AMINOPROPYL) 10H PHENOTHIAZINE; 10 (N METHOXYCARBONYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 2 CHLORO 10 (N METHANESULFONYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 2 CHLORO 10 (N METHOXYCARBONYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 2 TRIFLUOROMETHYL (N METHOXYCARBONYL 4 AMINOBUTYL) 10H PHENOTHIAZINE; 2 TRIFLUOROMETHYL 10 (N METHANESULFONYL 3 AMINOPROPYL) 10H PHENOTHIAZINE; 2 TRIFLUOROMETHYL 10 (N METHOXYCARBONYL 3 AMINOPROPYL) 10H PHENOTHIAZINE; AMINOPHENOTHIAZINE MALEATE; LIPOSOME; N ACYLPHENOTHIAZINE; PHENOTHIAZINE DERIVATIVE; PHENOTHIAZINE MALEATE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ENTHALPY; ERYTHROCYTE MEMBRANE; FLUORESCENCE; HEMOLYSIS; HUMAN; HUMAN CELL; LIPID MEMBRANE; MEMBRANE FLUIDITY; MICROCALORIMETRY; NORMAL HUMAN; POLARIZATION;

EID: 0042929904     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297154     Document Type: Article

References (26)

1. Nerdal, W., Gundersen, S. A., Thorsen, V. et al., Chlorpromazine interaction with glycerophospholipid liposomes studied by magic angle spinning solid state 13C-NMR and differential scanning calorimetry. Biochim. Biophys. Acta 1464, 165 (2000)
2. Hendrich, A. B., Wesolowska, O., Michalak, K., Trifluoroperazine induces dopamin formation in zwitterionic phosphatidylcholine but not in charged phosphatidylglycerol bilayers. Biochem. Biophys. Acta 1510, 414 (2001)
3. Sharom, F. J., The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity. Biochem. Soc. Transact. 25, 1088 (1997)
4. Pajeva, I. K., Wiese, M., Cordes, H. P. et al., Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing ability, J. Cancer Res. Clin. Oncol. 122, 27 (1996)
5. Agasosler, A. V., Tungodden, L. M., Cejka, D. et al., Chlorpromazine-induced increase in dipalmitoyl phosphatidyl serine surface area in monolayers at room temperature. Biochem. Pharmacol. 61, 817 (2001)
6. Mosior, M., Golini, E. S., Epand, R. M., Chemical specificity and physical properties of the lipid bilayer in the regulation of protein kinase C by anionic phospholipids: evidence for the lack of a specific binding site for phosphatidylserine. Proc. Natl. Acad. Sci. USA 93, 1907 (1996)
7. Grabski, R., Dewitt, J., De Bradeebeer, J. et al., Inhibition of T cell invasion across cultured fibroblast monolayers by phenothiazine-related calmoduline inhibitors: impairment of lymphocyte motility by trifluoperazine and chlorpromazine, and alteration of monolayer by pimozide. Biochem. Pharmacol. 61, 1313 (2001)
8. Kim, J., Mosior, M., Chung, L. A. et al., Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys J. 60, 135 (1991)
9. Ahtee, L., Some effects of phenothiazines and related compounds on blood platelets and red blood cells of rabbit. Surface activity of phenothiazines and related compounds. Am. Med. Exp. Fenn. 44, 453 (1966)
10. Ahtee, L., 5-Hydroxyltryptamine release from blood platelets and haemolysis of red blood cells of rabbit induced by phenothiazines and related compounds. Am. Med. Exp. Fenn. 44, 431 (1966)
11. Pajeva, I., Wiese, M., Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: A comparative molecular field analysis study. J. Med. Chem. 41, 1815 (1998)
12. Motohashi, N., Kawase, M., Kurihara, T. et al., Synthesis and antitumor activities of 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkylureas as potent anticancer agents. Anticancer Res. 16, 2525 (1996)
13. Huang, C. L., Guyton, C. L., Synthesis of nor1- and nor2- chlorpromazine derivatives. J. Pharm. Sci. 58, 267 (1969)
14. Dodge, J. T., Mitchell, C., Hanahan, D. J., Preparation and chemical characterization of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100, 119 (1963)
15. Wadkins, R. M., Houghton, P. J., The role of drug-lipid interactions in the biological activity of modulators of multidrug resistance. Biochim. Biophys. Acta, 1153, 225 (1993)
16. Ford, J. M., Prozialeck, W. C., Hait, W. N., Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance. Mol. Pharmacol. 35, 105 (1989)
17. Ramu, A., Ramu, N., Reversal of multidrug resistance by phenothiazines and structurally related compounds. Cancer Chemother. Pharmacol. 30, 165 (1992)
18. McIntosh, T. J., Differences in hydrocarbon chain tilt between hydrated phosphatidylethanolamine and phosphatidylcholine bilayers: a molecular packing model. Biophys. J. 29, 237 (1980)
19. O'Leary, T. J., Ross, P. D., Levin, I. W., Effect of anesthetic tetradecenols on phosphatidylcholine phase transitions. Implications for the mechanism of pretransition. Biophys. J. 50, 1053 (1986)
20. Heimburg, T., A model for the lipid pretransition: coupling of ripple formation with the chain-melting transition. Biophys. J. 78, 1154 (2000)
21. 31P NMR studies on the interaction of some phenothiazine derivatives with dipalmitoyl phosphatidylcholine model membranes. Biochim. Biophys. Acta 507, 185 (1978)
22. Hendrich, A. B., Michalak, K., Bobrowska, M. et al., Effect of spectrin on structure properties of lipid bilayers formed from mixtures of phospholipids. Fluorescence and microcalorimetric studies. Gen. Physiol. Biophys. 10, 333 (1991)
23. Roemer, J., Bickel, M. H., Interactions of chlorpromazine and imipramine with artificial membranes investigated by equilibrium dialysis, dual-wavelength photometry, and fluorimetry. Biochem. Pharm. 28, 799 (1979)
24. Minetti, M., Stasi, A. M. M. D., Involvement of erythrocyte skeletal proteins in the modulation of membrane fluidity by phenothiazines. Biochemistry 26, 8133 (1987)
25. Isomaa, B., Hagerstrand, H., Paatero, G., Shape transformations induced by amphiphiles in erythrocytes. Biochim. Biophys. Acta 899, 93 (1987)
26. Chen, J. Y., Huestis, W. H., Role of membrane lipid distribution in chlorpromazine-induced shape change of human erythrocytes. Biochim. Biophys. Acta 1323, 299 (1997)